Kimball AB, Alavi A, Jemec GB, Gottlieb A, Wei X, Wozniak MB, Uhlmann L, Martinez AL, Keefe D, Martin R, Chen L, Muscianisi E. Secukinumab in Moderate to Severe Hidradenitis Suppurativa: Primary Endpoint Analysis From the SUNSHINE and SUNRISE Phase 3 Trials. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s129. Available from: https://jofskin.org/index.php/skin/article/view/1991